Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix
O Ibraghimov-Beskrovnaya1, J M Ervasti, C J Leveille
1Howard Hughes Medical Institute, University of Iowa College of Medicine, Iowa City 52242.
Abstract:
The primary sequence of two components of the dystrophin-glycoprotein complex has been established by complementary, DNA cloning. The transmembrane 43K and extracellular 156K dystrophin-associated glycoproteins (DAGs) are encoded by a single messenger RNA and the extracellular 156K DAG binds laminin. Thus, the 156K DAG is a new laminin-binding glycoprotein which may provide a linkage between the sarcolemma and extracellular matrix. These results support the hypothesis that the dramatic reduction in the 156K DAG in Duchenne muscular dystrophy leads to a loss of a linkage between the sarcolemma and extracellular matrix and that this may render muscle fibres more susceptible to necrosis.
More Related Videos
Related Concept Videos
Pharmacokinetics: Overview
Drug Biotransformation: Overview
Prodrugs
Prodrugs help overcome...
Drug Distribution: Overview
Initially, the free drug in the...
Hepatic Drug Excretion: Enterohepatic Cycling
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration


